Clinical Trial Update: Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Fespixon Cream in dialysis patients with chronic diabetic foot ulcers; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Fespixon Cream

Snippet

Sponsor: Cathay General Hospital | Conditions: Chronic Diabetic Foot Ulcer | Phase 4 | Status: COMPLETED